Skip to main content

Peer Review reports

From: NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension

Original Submission
28 Nov 2019 Submitted Original manuscript
17 Dec 2019 Reviewed Reviewer Report - Vinicio de Jesus Perez
21 Jan 2020 Reviewed Reviewer Report - Fabrice Antigny
12 Feb 2020 Author responded Author comments - Eamon Mulvaney
Resubmission - Version 2
12 Feb 2020 Submitted Manuscript version 2
14 Feb 2020 Reviewed Reviewer Report - Vinicio de Jesus Perez
24 Feb 2020 Reviewed Reviewer Report - Fabrice Antigny
25 Feb 2020 Author responded Author comments - Eamon Mulvaney
Resubmission - Version 3
25 Feb 2020 Submitted Manuscript version 3
29 Feb 2020 Reviewed Reviewer Report - Fabrice Antigny
10 Mar 2020 Author responded Author comments - Eamon Mulvaney
Resubmission - Version 4
10 Mar 2020 Submitted Manuscript version 4
Publishing
12 Mar 2020 Editorially accepted
6 Apr 2020 Article published 10.1186/s12890-020-1113-2

You can find further information about peer review here.

Back to article page